Analysts Seem to Expect Further Disappointments From FedEx - Charts Not So Much
Let's look at their price charts and technical indicators, and draw some conclusions.
Selling Rotates Into Larger-Cap Names
Meanwhile, the latest economic data suggest the likelihood of a Fed rate cut at the next FOMC meeting.
Get Five Below While It's Low
With years of growth ahead for the company, and with the stock trading well off of its highs, now might be the time to take a look at Five Below.
Buffett Should Look at Kraft Heinz's Charts, Too, When Pondering His Investment
Shares of the food giant may not have made a bottom, but it will be interesting to see how the stock behaves from here.
AbbVie Joins Giant Acquisition Trend in Big Pharma With Allergan Deal
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
AbbVie Is Likely to Decline as Investors Digest Its Takeover Announcement
Let's look closer at the charts and indicators of ABBV.
2 Enigmatic Indices, Intriguing Oil, and Planet Fitness Slouches: Market Recon
Plus, a look at Ulta Beauty and a possible options play in the retailer.
Take-Two Interactive Looks Better on the Charts Than Activision Blizzard
Let's check out the charts of TTWO this morning.
Charts of the Day: The States of U.S. Gambling
A bit of context to simmer on following the big deal between Caesars and Eldorado.
AbbVie Fizzles, Gold, Bitcoin and (Some) Biotech Sizzles
AbbVie is dropping on Allergan deal announcement, momentum is weak outside certain pockets.